Clinical Research Directory
Browse clinical research sites, groups, and studies.
Aquamin® as an Adjuvant Intervention for Ulcerative Colitis
Sponsor: Muhammad N Aslam, MD
Summary
The purpose of this study is to determine if Aquamin® works as a potential treatment to improve symptoms and if it will induce remission in patients with mild Ulcerative Colitis and extend remission in Ulcerative Colitis in remission.
Official title: Aquamin®, a Multi-mineral Natural Product From Red Marine Algae, as an Adjuvant Intervention for Mild Ulcerative Colitis and Ulcerative Colitis in Remission
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2019-08-08
Completion Date
2027-12
Last Updated
2026-01-20
Healthy Volunteers
No
Conditions
Interventions
Aquamin®
4 capsules per day; 2 to be taken in the morning and 2 in the evening (containing approximately 800 mg calcium/day)
Placebo first then Aquamin®
4 capsules per day; 2 to be taken in the morning and 2 in the evening
Locations (1)
The University of Michigan
Ann Arbor, Michigan, United States